Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs

被引:58
作者
Hardy, P
Peri, KG
Lahaie, I
Varma, DR
Chemtob, S
机构
[1] UNIV MONTREAL,HOP ST JUSTINE,RES CTR,DEPT PEDIAT,MONTREAL,PQ H3T 1C5,CANADA
[2] UNIV MONTREAL,HOP ST JUSTINE,RES CTR,DEPT PHARMACOL,MONTREAL,PQ H3T 1C5,CANADA
[3] UNIV MONTREAL,HOP ST JUSTINE,RES CTR,DEPT OPHTHALMOL,MONTREAL,PQ H3T 1C5,CANADA
[4] MCGILL UNIV,DEPT THERAPEUT & PHARMACOL,MONTREAL,PQ,CANADA
关键词
nitric oxide; retina; choroid; cyclooxygenase; hyperoxia;
D O I
10.1161/01.RES.79.3.504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We tested the hypothesis that hyperoxia does not cause adequate constriction of choroidal vessels of the newborn (1 to 5 days old) pig, resulting in increased O-2 delivery to the retina, possibly due to excess production and/or effects of vasodilators such as nitric oxide (NO). Hyperoxia (100% O-2, 45 minutes) led to a decrease in retinal blood flow (RBF) of both newborn and juvenile (5 to 6 weeks old) pigs and also reduced choroidal blood flow (ChBF) in juvenile but not in newborn pigs; the absence of hyperoxia-induced ChBF response in the newborn was associated with a rise in choroidal O-2 delivery. Ibuprofen (prostaglandin G/H synthase inhibitor) and 1,3-dimethyl-2-thiourea (a free radical scavenger) did not modify the choroidal hemodynamic responses to hyperoxia in newborn pigs. However, in newborn animals treated with the NO synthase (NOS) inhibitor N-G-nitro-L-arginine methyl eater (L-NAME), hyperoxia caused a decrease in blood flow and O-2 delivery to the choroid. Consistent with these effects of L-NAME, hyperoxia induced an increase in choroidal cGMP in newborn pigs ventilated with 100% O-2 and stimulated nitrite production in isolated choroids exposed to hyperoxia from newborn but not juvenile pigs; these effects were inhibited by NOS blockers. Also, both constitutive and inducible NOS activities were higher in choroidal tissues from newborn than from juvenile animals. In addition, the vasorelaxant effect of the NO donor sodium nitroprusside in vitro was also greater on choroids from newborn than from juvenile pigs. Finally, L-NAME prevented the hyperoxia-induced increase in peroxidation products in the choroid of newborns. It is concluded that hyperoxia does not lead to a decrease in blood flow and O-2 delivery to the choroid of the newborn because of increased NO synthesis and effects; since the choroid is the main source of O-2 supply to the retina, the present data contribute in providing an explanation for the increased susceptibility of the immature neonate to hyperoxia-induced retinopathy.
引用
收藏
页码:504 / 511
页数:8
相关论文
共 61 条
[1]   INCREASED THROMBOXANE-MEDIATED CONTRACTIONS OF RETINAL-VESSELS OF NEWBORN PIGS TO PEROXIDES [J].
ABRAN, D ;
VARMA, DR ;
CHEMTOB, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (02) :H628-H632
[3]   REGIONAL, SEGMENTAL, AND TEMPORAL HETEROGENEITY OF CEREBRAL VASCULAR AUTO-REGULATION [J].
BAUMBACH, GL ;
HEISTAD, DD .
ANNALS OF BIOMEDICAL ENGINEERING, 1985, 13 (3-4) :303-310
[4]   EFFECTS OF INDOMETHACIN ON REGIONAL BLOOD-FLOW IN CONSCIOUS RABBITS - MICROSPHERE STUDY [J].
BILL, A .
ACTA PHYSIOLOGICA SCANDINAVICA, 1979, 105 (04) :437-442
[5]  
Bill A., 1984, HDB PHYSL 2, P1001
[6]  
BKAILY G, 1994, IONIC CHANNELS VASCU, P87
[7]  
BLOODWORTH J. M. B., 1965, EXP EYE RES, V4, P174, DOI 10.1016/S0014-4835(65)80029-X
[8]   RETINAL SUPEROXIDE-DISMUTASE ACTIVITY IN NEWBORN KITTENS EXPOSED TO NORMOBARIC HYPEROXIA EFFECT OF VITAMIN-E [J].
BOUGLE, D ;
VERT, P ;
REICHART, E ;
HARTEMANN, D ;
HENG, EL .
PEDIATRIC RESEARCH, 1982, 16 (05) :400-402
[9]   REDUCTION OF CANINE MYOCARDIAL INFARCT SIZE BY A DIFFUSIBLE REACTIVE OXYGEN METABOLITE SCAVENGER - EFFICACY OF DIMETHYLTHIOUREA GIVEN AT THE ONSET OF REPERFUSION [J].
CARREA, FP ;
LESNEFSKY, EJ ;
REPINE, JE ;
SHIKES, RH ;
HORWITZ, LD .
CIRCULATION RESEARCH, 1991, 68 (06) :1652-1659
[10]   ONTOGENY OF RESPONSES OF RABBIT AORTA TO ATRIAL-NATRIURETIC-FACTOR AND ISOPROTERENOL [J].
CHEMTOB, S ;
GUEST, I ;
POTVIN, W ;
VARMA, DR .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1991, 16 (02) :108-115